The tumor neoantigen burden (IGS2) was not related to other axes of the immunogram, including T cell immunity (IGS1), priming and activation (IGS3), trafficking and infiltration (IGS4), recognition of tumor cells (IGS5), inhibitor cells (IGS6), checkpoint expression (IGS6), and inhibitor molecules (IGS8) (Supplementary Figure 2). Here, AMN is linked to neoplasm.